These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 12654442

  • 1. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
    Martenson JA, Vigliotti AP, Pitot HC, Geeraerts LH, Sargent DJ, Haddock MG, Ghosh C, Keppen MD, Fitch TR, Goldberg RM.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1305-10. PubMed ID: 12654442
    [Abstract] [Full Text] [Related]

  • 2. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
    Pipas JM, Mitchell SE, Barth RJ, Vera-Gimon R, Rathmann J, Meyer LP, Wagman RS, Lewis LD, McDonnell C, Colacchio TA, Perez RP.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1317-22. PubMed ID: 11483344
    [Abstract] [Full Text] [Related]

  • 3. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.
    Yavuz AA, Aydin F, Yavuz MN, Ilis E, Ozdemir F.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):974-81. PubMed ID: 11704320
    [Abstract] [Full Text] [Related]

  • 4. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
    Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM.
    Ann Oncol; 2008 Jan 15; 19(1):86-91. PubMed ID: 17878176
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
    Allen AM, Zalupski MM, Robertson JM, Eckhauser FE, Simone D, Brown D, Hejna G, Normolle D, Lawrence TS, McGinn CJ.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1461-7. PubMed ID: 15275733
    [Abstract] [Full Text] [Related]

  • 6. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
    Joensuu TK, Kiviluoto T, Kärkkäinen P, Vento P, Kivisaari L, Tenhunen M, Westberg R, Elomaa I.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):444-52. PubMed ID: 15380578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer.
    Robertson JM, Margolis J, Jury RP, Balaraman S, Cotant MB, Ballouz S, Boxwala IG, Jaiyesimi IA, Nadeau L, Hardy-Carlson M, Marvin KS, Wallace M, Ye H.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e187-92. PubMed ID: 21549514
    [Abstract] [Full Text] [Related]

  • 11. Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.
    Mishra G, Butler J, Ho C, Melin S, Case LD, Ennever PR, Magrinat GC, Bearden JD, Minotto DC, Howerton R, Levine E, Blackstock AW.
    Am J Clin Oncol; 2005 Aug 01; 28(4):345-50. PubMed ID: 16062075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M, Kovac V, Smrdel U, Strojan P.
    J Thorac Oncol; 2006 Sep 01; 1(7):662-6. PubMed ID: 17409933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.
    Chiorean EG, Schneider BP, Akisik FM, Perkins SM, Anderson S, Johnson CS, DeWitt J, Helft P, Clark R, Johnston EL, Spittler AJ, Deluca J, Bu G, Shahda S, Loehrer PJ, Sandrasegaran K, Cardenes HR.
    Int J Radiat Oncol Biol Phys; 2014 Jun 01; 89(2):284-91. PubMed ID: 24726286
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.
    McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, Brown D, Hejna G, Strawderman M, Normolle D, Lawrence TS.
    J Clin Oncol; 2001 Nov 15; 19(22):4202-8. PubMed ID: 11709563
    [Abstract] [Full Text] [Related]

  • 17. Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.
    Rachamalla R, Malamud S, Grossbard ML, Mathew S, Dietrich M, Kozuch P.
    Anticancer Drugs; 2004 Mar 15; 15(3):211-7. PubMed ID: 15014353
    [Abstract] [Full Text] [Related]

  • 18. Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
    Caffo O, Fellin G, Graffer U, Valduga F, Bolner A, Luciani L, Tomio L, Galligioni E.
    Int J Radiat Oncol Biol Phys; 2003 Dec 01; 57(5):1310-6. PubMed ID: 14630267
    [Abstract] [Full Text] [Related]

  • 19. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.
    Blackstock AW, Bernard SA, Richards F, Eagle KS, Case LD, Poole ME, Savage PD, Tepper JE.
    J Clin Oncol; 1999 Jul 01; 17(7):2208-12. PubMed ID: 10561277
    [Abstract] [Full Text] [Related]

  • 20. A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma.
    Raftery L, Tepper JE, Goldberg RM, Blackstock AW, Aklilu M, Bernard SA, Ivanova A, Davies JM, O'Neil BH.
    Am J Clin Oncol; 2013 Jun 01; 36(3):250-3. PubMed ID: 22547007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.